Biologics
Josh Sandberg
Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.
BELGRADE – A group of NUST MISIS scientists developed an innovative technology for producing a bioactive coating with an antibacterial effect. This technology will be used in medicine and allows scientists to cover implants with coating that protects human body from inflammation, helps to avoid implant rejection and reduces the postoperative period.
Occurrence of inflammatory responses is one of the main problems that hinder fast implant integration into living tissue. A highly adhesive biofilm forms on the surface of the implant as a result of bacteria and fungi colonization. This biofilm is not easy to remove by traditional drug therapy.
Covering implants with the antibacterial coating developed by NUST MISIS scientists is an effective way of solving this problem.